266 related articles for article (PubMed ID: 2915408)
1. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987.
Des Jarlais DC; Friedman SR; Novick DM; Sotheran JL; Thomas P; Yancovitz SR; Mildvan D; Weber J; Kreek MJ; Maslansky R
JAMA; 1989 Feb; 261(7):1008-12. PubMed ID: 2915408
[TBL] [Abstract][Full Text] [Related]
2. HIV infection among intravenous drug users: epidemiology and risk reduction.
Des Jarlais DC; Friedman SR
AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
[TBL] [Abstract][Full Text] [Related]
3. HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention.
Des Jarlais DC; Friedman SR; Stoneburner RL
Rev Infect Dis; 1988; 10(1):151-8. PubMed ID: 3281219
[TBL] [Abstract][Full Text] [Related]
4. HIV and intravenous drug use.
Des Jarlais DC; Friedman SR
AIDS; 1988; 2 Suppl 1():S65-9. PubMed ID: 3147682
[TBL] [Abstract][Full Text] [Related]
5. HIV infection among persons who inject illicit drugs: problems and prospects.
Des Jarlais DC; Friedman SR
J Acquir Immune Defic Syndr (1988); 1988; 1(3):267-73. PubMed ID: 3216310
[TBL] [Abstract][Full Text] [Related]
6. Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU).
D'Aquila RT; Williams AB
Yale J Biol Med; 1987; 60(6):545-67. PubMed ID: 3324506
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
Selwyn PA; Hartel D; Lewis VA; Schoenbaum EE; Vermund SH; Klein RS; Walker AT; Friedland GH
N Engl J Med; 1989 Mar; 320(9):545-50. PubMed ID: 2915665
[TBL] [Abstract][Full Text] [Related]
8. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
[TBL] [Abstract][Full Text] [Related]
9. Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.
Des Jarlais DC; Friedman SR; Hopkins W
Ann Intern Med; 1985 Nov; 103(5):755-9. PubMed ID: 4051350
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for human immunodeficiency virus infection in intravenous drug users.
Schoenbaum EE; Hartel D; Selwyn PA; Klein RS; Davenny K; Rogers M; Feiner C; Friedland G
N Engl J Med; 1989 Sep; 321(13):874-9. PubMed ID: 2770823
[TBL] [Abstract][Full Text] [Related]
11. Trends in the AIDS epidemic among New York City's injection drug users: localized or citywide?
Rockwell R; Deren S; Goldstein MF; Friedman SR; Des Jarlais DC
J Urban Health; 2002 Mar; 79(1):136-46. PubMed ID: 11937622
[TBL] [Abstract][Full Text] [Related]
12. A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City.
Stoneburner RL; Des Jarlais DC; Benezra D; Gorelkin L; Sotheran JL; Friedman SR; Schultz S; Marmor M; Mildvan D; Maslansky R
Science; 1988 Nov; 242(4880):916-9. PubMed ID: 3187532
[TBL] [Abstract][Full Text] [Related]
13. HIV infection in heterosexual female intravenous drug users in New York City, 1977-1980.
Thomas P; O'Donnell R; Williams R; Chiasson MA
N Engl J Med; 1988 Aug; 319(6):374. PubMed ID: 3393203
[No Abstract] [Full Text] [Related]
14. Intravenous drug use and the heterosexual transmission of the human immunodeficiency virus. Current trends in New York City.
Des Jarlais DC; Wish E; Friedman SR; Stoneburner R; Yancovitz SR; Mildvan D; el-Sadr W; Brady E; Cuadrado M
N Y State J Med; 1987 May; 87(5):283-6. PubMed ID: 3473333
[No Abstract] [Full Text] [Related]
15. The epidemic of acquired immunodeficiency syndrome (AIDS) and suggestions for its control in drug abusers.
Marmor M; Des Jarlais DC; Friedman SR; Lyden M; el-Sadr W
J Subst Abuse Treat; 1984; 1(4):237-47. PubMed ID: 6100315
[TBL] [Abstract][Full Text] [Related]
16. Condom use among male injecting-drug users--New York City, 1987-1990.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1992 Aug; 41(34):617-20. PubMed ID: 1501604
[TBL] [Abstract][Full Text] [Related]
17. Heterosexual human immunodeficiency virus transmission among the middle class.
Glaser JB; Strange TJ; Rosati D
Arch Intern Med; 1989 Mar; 149(3):645-9. PubMed ID: 2919939
[TBL] [Abstract][Full Text] [Related]
18. Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users.
Des Jarlais DC; Friedman SR; Marmor M; Cohen H; Mildvan D; Yancovitz S; Mathur U; el-Sadr W; Spira TJ; Garber J
AIDS; 1987 Jul; 1(2):105-11. PubMed ID: 2896511
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of antibodies to human immunodeficiency virus among intravenous drug users in Israel--association with travel abroad.
Dan M; Rock M; Bar-Shany S
Int J Epidemiol; 1989 Mar; 18(1):239-41. PubMed ID: 2722371
[TBL] [Abstract][Full Text] [Related]
20. Implications of the revised surveillance definition: AIDS among New York City drug users.
Des Jarlais DC; Wenston J; Friedman SR; Sotheran JL; Maslansky R; Marmor M; Yancovitz S; Beatrice S
Am J Public Health; 1992 Nov; 82(11):1531-3. PubMed ID: 1359800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
